402 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Kelsen
    Kelsen
  4. Seidman
    Seidman
  5. Motzer
    Motzer
  6. Saltz
    Saltz
  7. Aghajanian
    Aghajanian
  8. Spriggs
    Spriggs
  9. Kemeny
    Kemeny
  10. Kris
    Kris

Groups

  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  8. Epidemiology and Biostatistics (49)
  9. Center for Pancreatic Cancer Research (44)
  10. Hematologic Malignancies, Division of (44)
  1. "drug administration schedule"
Formats
  1. Journal Article (392)
  2. Conference Paper (10)
Groups
  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)

More Groups

People
  1. Clifford Hudis (32)
  2. Larry Norton (30)
  3. Andrew Seidman (25)
  4. David Kelsen (25)
  5. Nancy Kemeny (24)
  6. Robert Motzer (24)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Cancer (34)
  3. Clinical Cancer Research (23)
  4. Seminars in Oncology (18)
  5. Gynecologic Oncology (16)
  6. JNCI: Journal of the National Cancer Institute (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (62)
  3. Wiley Blackwell (39)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (27)
  6. Springer (26)

More Publishers

Results (402)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas
    Journal Article

    Hagemeister, F.; Rodriguez, M. A.; Deitcher, S. R.; Younes, A.; Fayad, L.; Goy, A.; Dang, N. H.; Forman, A.; McLaughlin, P.; Medeiros, L. J.; more...
    British Journal of Haematology (2013)

    Fulltext@MSK | Save
  • Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: A Children's Oncology Group report
    Journal Article

    Barth, M. J.; Goldman, S.; Smith, L.; Perkins, S.; Shiramizu, B.; Gross, T. G.; Harrison, L.; Sanger, W.; Geyer, M. B.; Giulino-Roth, L.; more...
    British Journal of Haematology (2013)

    Fulltext@MSK | Save
  • Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older
    Journal Article

    Feldman, D. R.; Voss, M. H.; Jacobsen, E. P.; Jia, X.; Suarez, J. A.; Turkula, S.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.; Patil, S.
    Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma
    Journal Article

    Catalanotti, F.; Solit, D. B.; Pulitzer, M. P.; Berger, M. F.; Scott, S. N.; Iyriboz, T.; Lacouture, M. E.; Panageas, K. S.; Wolchok, J. D.; Carvajal, R. D.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Hamlin, P. A. Jr; Perales, M. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized ewing sarcoma: A report from the children's oncology group
    Journal Article

    Womer, R. B.; West, D. C.; Krailo, M. D.; Dickman, P. S.; Pawel, B. R.; Grier, H. E.; Marcus, K.; Sailer, S.; Healey, J. H.; Dormans, J. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101
    Journal Article

    Shulman, L. N.; Cirrincione, C. T.; Berry, D. A.; Becker, H. P.; Perez, E. A.; O'Regan, R.; Martino, S.; Atkins, J. N.; Mayer, E.; Schneider, C. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors
    Journal Article

    Merchant, M. S.; Geller, J. I.; Baird, K.; Chou, A. J.; Galli, S.; Charles, A.; Amaoko, M.; Rhee, E. H.; Price, A.; Wexler, L. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Aflibercept and docetaxel versus docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: A randomized, controlled phase III trial
    Journal Article

    Ramlau, R.; Gorbunova, V.; Ciuleanu, T. E.; Novello, S.; Ozguroglu, M.; Goksel, T.; Baldotto, C.; Bennouna, J.; Shepherd, F. A.; Le-Guennec, S.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma
    Journal Article

    Naing, A.; Aghajanian, C.; Raymond, E.; Olmos, D.; Schwartz, G.; Oelmann, E.; Grinsted, L.; Burke, W.; Taylor, R.; Kaye, S.; more...
    British Journal of Cancer (2012)

    Fulltext@MSK | Save